Your browser doesn't support javascript.
loading
Botulinum toxin A (BoNT/A) for the treatment of depression: A randomized, double-blind, placebo, controlled trial in China.
Li, Yang; Zhu, Ting; Shen, Tingting; Wu, Wenqi; Cao, Jiaqian; Sun, Jiawei; Liu, Jing; Zhou, Xuping; Jiang, Caixia; Tang, Zhen; Liu, Tong; Chen, Lihua; Hu, Hua; Luo, Weifeng.
Afiliação
  • Li Y; Department of Neurology and Clinical Research Center of Neurological Disease, The Second Affiliated Hospital of Soochow University, Suzhou 215004, China.
  • Zhu T; Department of Neurology and Clinical Research Center of Neurological Disease, The Second Affiliated Hospital of Soochow University, Suzhou 215004, China.
  • Shen T; Department of Neurology and Clinical Research Center of Neurological Disease, The Second Affiliated Hospital of Soochow University, Suzhou 215004, China.
  • Wu W; Department of Neurology and Clinical Research Center of Neurological Disease, The Second Affiliated Hospital of Soochow University, Suzhou 215004, China.
  • Cao J; Department of Neurology and Clinical Research Center of Neurological Disease, The Second Affiliated Hospital of Soochow University, Suzhou 215004, China.
  • Sun J; Department of Neurology and Clinical Research Center of Neurological Disease, The Second Affiliated Hospital of Soochow University, Suzhou 215004, China.
  • Liu J; Department of Neurology and Clinical Research Center of Neurological Disease, The Second Affiliated Hospital of Soochow University, Suzhou 215004, China.
  • Zhou X; Department of Neurology and Clinical Research Center of Neurological Disease, The Second Affiliated Hospital of Soochow University, Suzhou 215004, China.
  • Jiang C; Department of Psychiatry, Suzhou Guangji Hospital, The Affiliated Guangji Hospital of Soochow University, Suzhou 215000, China.
  • Tang Z; Department of Psychiatry, Suzhou Guangji Hospital, The Affiliated Guangji Hospital of Soochow University, Suzhou 215000, China.
  • Liu T; Institute of Pain Medicine and Special Environmental Medicine, Nantong University, Nantong 226019, China.
  • Chen L; Department of Nutrition and Food Hygiene, School of Public Health, Nantong University, Jiangsu 226019, China.
  • Hu H; Department of Neurology and Clinical Research Center of Neurological Disease, The Second Affiliated Hospital of Soochow University, Suzhou 215004, China. Electronic address: sz_huhua@126.com.
  • Luo W; Department of Neurology and Clinical Research Center of Neurological Disease, The Second Affiliated Hospital of Soochow University, Suzhou 215004, China. Electronic address: lwfwxx@126.com.
J Affect Disord ; 318: 48-53, 2022 12 01.
Article em En | MEDLINE | ID: mdl-36063974
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Toxinas Botulínicas Tipo A Tipo de estudo: Clinical_trials Limite: Humans País/Região como assunto: Asia Idioma: En Revista: J Affect Disord Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China País de publicação: Holanda
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Toxinas Botulínicas Tipo A Tipo de estudo: Clinical_trials Limite: Humans País/Região como assunto: Asia Idioma: En Revista: J Affect Disord Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China País de publicação: Holanda